Advertisement

Biopiracy

  • P. K. SatheeshkumarEmail author
  • Anoop Narayanan
Chapter

Abstract

In the nineteenth century, globalization due to industrial revolution made significant impact in the intra- and international exchange of knowledge and goods. Even though there were many constructive features, globalization propelled few detrimental events like monopolizing the economy by a few countries and biopiracy. In simple words, the term biopiracy refers to the unethical and illegal exploitation of one’s knowledge or resource without prior consent or benefit-sharing agreement by a third party through intellectual property right claims. The phenomenon is present in almost all commercial fields, especially in pharmaceutical, food and cosmetic industry. In a general modus operandi, the information gained will be skilfully manipulated to a patent, through which the information will become the intellectual property of the pirate. Superficially, there may not be any similarity with the prior knowledge, but either the resource or the product will be monopolized by the biopirate, thus preventing the actual inventor from utilizing it. It was noted that the benefits were always accounted to the developed countries even though 90 % of the information was from the developing/underdeveloped nations. Heavy exploitation accompanied with the inevitable destruction of biodiversity forces the organizations like UN to enforce strict means to protect the universe. At present, there are 170 countries that agreed to the fair sharing of information and profit and to the sustainable utilization of natural resources.

Keywords

Bioprospecting Traditional knowledge Benefit sharing Intellectual property Biodiversity 

References

  1. Amir-Aslani A, Mangematin V (2009) The future of drug discovery and development: shifting emphasis towards personalized medicine. Technol Forecast Soc Change. Doi:  10.1016/j.techfore. 2009.09.005
  2. Arenas D, Lozano JP, Albareda L (2009) The role of NGOs in CSR: mutual perceptions among stakeholders. J Business Ethics 88:175–197CrossRefGoogle Scholar
  3. Arrieta JM, Arnaud-Haond S, Duarte CM (2010) What lies underneath: conserving the oceans’ genetic resources. Proc Natl Acad Sci USA 107(43):18318–18324CrossRefPubMedPubMedCentralGoogle Scholar
  4. Aoki K (2009) Symposium: when worlds collide: intellectual property at the interface between systems of knowledge creation: panel II: knowledge creations systems on the national stage: “Free Seeds, Not Free Beer”: participatory plant breeding, open source seeds, and acknowledging user innovation in agriculture. 77 Fordham L. Rev. 2275Google Scholar
  5. Barrett CB, Travis AJ, Dasgupta DP (2011) On Biodiversity conservation and poverty traps. Proc Natl Acad Sci USA 108:13907–13912Google Scholar
  6. Bhattacharya S, Chattopadhyay DJ, Mukhopadhyay A (2013) Changing dimensions of food security in a globalized world: a review of the perspectives for environment, economy and health. Int Res J Environ Sci 2(3):67–73Google Scholar
  7. Bonn Guidelines (2002) Bonn guidelines on access to genetic resources and fair and equitable sharing of the benefits arising out of their utilization. United National Environmental Programme (UNEP) Convention on Biological Diversity. http://www.cbd.int/abs/bonn.shtml
  8. Chaudhuri SK (2003) Microbial biopiracy in India; How to fight back? J Intellect Prop Rights 8:389–399Google Scholar
  9. Christoffersen LP, Fish SC (1999) Standing up to Biopiracy foresting sustainable development through bioprospecting. Resour Afr 7:23–24Google Scholar
  10. Cunha MP, Guimarães-Costa N, Rego A, Clegg SR (2010) Leading and following (Un) ethically in Limen. J Business Ethics 97:189–206CrossRefGoogle Scholar
  11. Edelman LB (1992) Legal ambiguity and symbolic structures: organizational mediation of civil right law. Am J Sociol 97:1531–1576CrossRefGoogle Scholar
  12. Gibbons S (2008) Phytochemicals for bacterial resistance--strengths, weaknesses and opportunities. Planta Medica 74:594–602CrossRefPubMedGoogle Scholar
  13. Gupta C, Prakash D, Gupta S (2014) Natural useful therapeutic products from microbes. J Microbiol Exp 1(1):00006. DOI: 10.15406/ jmen.2014.01.00006Google Scholar
  14. Gurang N, Ray S, Bose S, Rai V (2013) A broader view: microbial enzymes and their relevance in industries, medicine, and beyond. BioMed Res Int.  dx.doi.org/10.1155/2013/329121
  15. Harvey N (2001) Globalisation and resistance in post-cold war Mexico: difference, citizenship, and biodiversity conflicts in Chiapas. Third World Q 22:1045–1061CrossRefGoogle Scholar
  16. Hayden C (2003) When nature goes public: the making and unmaking of bioprospecting in Mexico. Princeton University Press, PrincetonGoogle Scholar
  17. Hayden C (2007) Taking as giving: bioscience, exchange, and the politics of benefit-sharing. Soc Stud Sci 37:729–758CrossRefGoogle Scholar
  18. Jefferson OA, Köllhofer D, Ehrich TH, Jefferson RA (2015) Gene patent practice across plant and human genomes. Nat Biotechnol 33(10):33–38CrossRefGoogle Scholar
  19. Koehn F, Carter GT (2005) The evolving role of natural products in drug discovery. Nature 4:206–220Google Scholar
  20. Kurien K, Das A (2011) Nagoya Protocol and its implications on pharmaceutical industry. Beroe Inc. Publication, pp 3–6Google Scholar
  21. Ministry of Environment and forests (2010) National consultations on BT brinjals: a primer on concerns, issues and prospects. Centre for environment education, India.Google Scholar
  22. Nazarea VD (2006) Local knowledge and memory in biodiversity conservation. Annu Rev Anthropol 35:317–335CrossRefGoogle Scholar
  23. Nigh R (2002) Maya medicine in the biological gaze: bioprospecting research as herbal fetishism. Curr Anthropol 43:451–477CrossRefPubMedGoogle Scholar
  24. Peterson K (2001) Benefit sharing for All?: bioprospecting NGOs, intellectual property rights, New Governmentalities. PoLAR 24:78–91CrossRefGoogle Scholar
  25. RAFI Communiqué, “Biopiracy Update: A Global Pandemic,” Sept-October, 1995.Google Scholar
  26. Rose J, Quave CL, Islam G (2012) The four-sided triangle of ethics in bioprospecting: pharmaceutical business, international politics, socio-environmental responsibility and the importance of local stakeholders. Ethnobiol Conserv 1:1–25Google Scholar
  27. Samuels J (2012) Genetically engineered Bt brinjal and the implications for plant biodiversity – revisited. Greenpeace, IndiaGoogle Scholar
  28. Shankar D (1997) Traditional medicine and biopiracy. Ancient Sci Life 17(1):67–71Google Scholar
  29. Shiva V (1997) Biopiracy: the Plunder of nature and knowledge. South End Press, Cambridge, MAGoogle Scholar
  30. Soejarto DD, Fong HH, Tan GT, Zhang HJ, Ma CY, Franzblau SG, Gyllenhaal C, Riley MC, Kadushin MR, Pezzuto JM, Xuan LT, Hiep NT, Hung NV, Vu BM, Loc PK, Dac LX, Binh LT, Chien NQ, Hai NV, Bich TQ, Cuong NM, Southavong B, Sydara K, Bouamanivong S, Ly HM, Thuy TV, Rose WC, Dietzman GR (2005) Ethnobotany/ethnopharmacology and mass bioprospecting: issues on intellectual property and benefit-sharing. J Ethnopharmacol 100:15–22CrossRefPubMedGoogle Scholar
  31. Walters D (2011) Plant defence: Warding off attack by pathogens, herbivores and parasitic plants. Wiley-Blackwell, LondonGoogle Scholar
  32. Wang R (2000) Strategic rice research: Impossible problems, possible solutions. Presentation at CGIAR International Centers Week, Washington, DC, 26 October 2000Google Scholar
  33. Yusuf M (2010) Ethical issues in the use of the terminator seed technology. Afr J Agric Res 9(52):8901–8904Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2017

Authors and Affiliations

  1. 1.Division of MicrobiologyJawaharlal Nehru Tropical Botanic Garden and Research InstituteThiruvananthapuramIndia
  2. 2.Department of Biological SciencesPurdue UniversityWest LafayetteUSA

Personalised recommendations